LCGC Magazine is pleased to announce the addition of Michael W. Dong, PhD, to its editorial advisory board.
LCGC
Magazine is pleased to announce the addition of Michael W. Dong, PhD, to its editorial advisory board.
Dong is a senior scientist in the Small Molecule Drug Discovery group at Genentech (South San Francisco, CA), a position he has held since 2007. He formerly served as a research director at Synomics Pharma (Wareham, MA), a research fellow at Purdue Pharma (Cranbury, NJ), a senior staff scientist at Applied Biosystems/PerkinElmer (Foster City, CA), and a section head in Hoechst Celanese (Bridgewater, NJ).
Don has conducted training courses at national meetings (ACS, Pittcon, EAS AAPS, HPLC) on High Performance Liquid Chromatography (HPLC) in pharmaceutical analysis and Drug Metabolism and Pharmacokinetics, HPLC method development, ultra high-pressure LC, the drug development process for scientists, and drug quality. His publishing credentials include more than 80 publications in chromatography and analytical chemistry. He has authored a bestseller in chromatography, Modern HPLC for Practicing Scientists (Wiley, 2006) and co-edited Handbook of Pharmaceutical Analysis by HPLC (Elsevier/Academic Press, 2005).
Dong received his doctorate in analytical chemistry from the City University of New York, and a certificate in biotechnology from the University of California, Santa Cruz.
An LC–HRMS Method for Separation and Identification of Hemoglobin Variant Subunits
March 6th 2025Researchers from Stanford University’s School of Medicine and Stanford Health Care report the development of a liquid chromatography high-resolution mass spectrometry (LC–HRMS) method for identifying hemoglobin (Hb) variants. The method can effectively separate several pairs of normal and variant Hb subunits with mass shifts of less than 1 Da and accurately identify them in intact-protein and top-down analyses.
The Next Frontier for Mass Spectrometry: Maximizing Ion Utilization
January 20th 2025In this podcast, Daniel DeBord, CTO of MOBILion Systems, describes a new high resolution mass spectrometry approach that promises to increase speed and sensitivity in omics applications. MOBILion recently introduced the PAMAF mode of operation, which stands for parallel accumulation with mobility aligned fragmentation. It substantially increases the fraction of ions used for mass spectrometry analysis by replacing the functionality of the quadrupole with high resolution ion mobility. Listen to learn more about this exciting new development.